Global Biotechnology Services Market Size, Share, and Trends - Forecast 2026-2032 | AI, Outsourcing, and Advanced Therapies Fuel 11.99% CAGR and a USD 531.07 Billion Opportunity by 2032
Dublin, Oct. 30, 2026 (GLOBE NEWSWIRE) -- "Biotechnology Services Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
This market research report examines the global biotechnology services market, which is projected to reach USD 268.83 billion in 2026 and expand at a compound annual growth rate (CAGR) of 11.99% to USD 531.07 billion by 2032. It assesses the scientific, technological, operational, and regional factors shaping demand across research, development, testing, manufacturing, regulatory compliance, and commercialization.
Market Scope and Growth Drivers
Biotechnology services support biopharmaceutical, agricultural, industrial, and diagnostic applications. Growth is being driven by rising demand for scientific expertise, flexible infrastructure, quality assurance, and integrated support across increasingly complex development pathways.
The analysis supports strategic planning by clarifying where specialized capabilities and integrated service models may create attractive growth opportunities.
Integrated Workflows and Service Innovation
The market is shifting from isolated project support toward coordinated, multidisciplinary workflows. Connecting discovery, validation, scale-up, production, and regulatory activities can reduce handoff risks, preserve technical knowledge, and improve development continuity.
Service providers increasingly need to combine scientific depth with robust quality systems, secure data practices, regulatory adaptability, and dependable supply networks. These insights can inform partnership selection, outsourcing strategies, and investment priorities across the development lifecycle.
Artificial Intelligence in Biotechnology Services
Artificial intelligence is influencing experimental design, biomarker identification, molecular modeling, image analysis, process optimization, document review, and predictive quality monitoring. Integration with laboratory information systems, manufacturing records, and regulatory workflows can strengthen decision support and enable earlier identification of deviations.
Effective adoption depends on:
Regional Market Dynamics
Country-level coverage includes major biotechnology markets such as the United States, China, India, Japan, South Korea, Germany, France, the United Kingdom, Canada, Australia, Brazil, Mexico, Italy, Spain, and Russia. Regional comparisons provide a practical foundation for evaluating market-entry options and mitigating regulatory or infrastructure risks.
Strategic Priorities for Industry Participants
Key Takeaways from This Report
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biotechnology Services Market, by Service Type
7.1. Introduction
7.2. Bioinformatics Services
7.2.1. Data Analysis
7.2.2. Software Solutions
7.3. Bioprocessing
7.3.1. Fermentation Services
7.3.2. Purification Services
7.4. Cell Therapy Services
7.4.1. Allogeneic Cell Therapy
7.4.2. Autologous Cell Therapy
7.5. Custom Cell Line Development
7.5.1. Mammalian Cell Line
7.5.2. Microbial Cell Line
7.6. Drug Discovery
7.6.1. Biologics Discovery
7.6.2. Small Molecule Discovery
7.7. Genomic Services
7.7.1. PCR Services
7.7.2. Sequencing Services
8. Biotechnology Services Market, by Technology
8.1. Introduction
8.2. Analytical Techniques
8.2.1. Chromatography
8.2.2. Mass Spectrometry
8.3. Cell Culture Technologies
8.4. Genomic Technologies
8.4.1. Next Generation Sequencing
8.4.2. PCR Technology
8.5. Imaging Technologies
8.5.1. Flow Cytometry
8.5.2. Microscopy
9. Biotechnology Services Market, by Application
9.1. Introduction
9.2. Diagnostic
9.2.1. Biomarker Discovery
9.2.2. Companion Diagnostics
9.3. Drug Discovery
9.3.1. Lead Optimization
9.3.2. Target Identification
9.4. Research
9.4.1. Basic Research
9.4.2. Translational Research
9.5. Therapeutic Development
9.5.1. Clinical Trials
9.5.2. Preclinical Testing
10. Biotechnology Services Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Government Labs
10.2.2. University Labs
10.3. Biotech Companies
10.4. Contract Research Organizations
10.4.1. Clinical Research
10.4.2. Preclinical Research
10.5. Pharmaceutical Companies
11. Biotechnology Services Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Biotechnology Services Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Biotechnology Services Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Agilent Technologies, Inc.
15.2. Catalent Inc.
15.3. Charles River Laboratories International, Inc.
15.4. Crown Bioscience, Inc.
15.5. Danaher Corporation
15.6. Eurofins Scientific SE
15.7. Fortrea Holdings Inc.
15.8. GE HealthCare Technologies Inc.
15.9. GenScript Biotech Corporation
15.10. ICON PLC
15.11. IQVIA Holdings Inc.
15.12. KBI Biopharma Inc.
15.13. Laboratory Corporation of America Holdings
15.14. Lonza Group AG
15.15. Medpace Holdings Inc.
15.16. Novotech Health Holdings Ltd.
15.17. Parexel International Corporation
15.18. PerkinElmer, Inc.
15.19. Recipharm AB
15.20. Samsung Biologics Co. Ltd.
15.21. Sartorius AG
15.22. SGS SA
15.23. Syngene International Limited
15.24. Thermo Fisher Scientific Inc.
15.25. WuXi AppTec Co., Ltd.
16. Key Experts
LIST OF FIGURES [19]
LIST OF TABLES [345]
For more information about this report visit https://www.researchandmarkets.com/r/9o0cyq
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.